)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
Bloomage BioTechnology
Bloomage BioTechnology (688363) investor relations material
Bloomage BioTechnology Q3 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2026 earnings summary29 Oct, 2026
Executive summary
Q3 revenue was RMB 839.84m, down 6.96% YoY; attributable net income rose 5.62% to RMB 33.30m as operating efficiency improved.
Strategy emphasized business-structure optimization, tighter cost control, AI deployment and synthetic biology to shift from scale expansion toward quality growth.
Financial highlights
Q3 revenue was RMB 839.84m, down 6.96% YoY; total profit was RMB 37.46m, down 17.94% YoY.
Q3 attributable net income was RMB 33.30m, up 5.62% YoY; adjusted for non-recurring items, net income was RMB 30.99m, up 165.00% YoY.
9M revenue was RMB 2.596bn, down 17.94% YoY; attributable net income was RMB 186.09m, down 26.27% YoY.
9M total profit was RMB 189.54m, down 34.98% YoY; basic EPS was RMB 0.39, down 25.00%.
Outlook and guidance
Priorities include AI-enabled operations, synthetic biology, full-industry-chain collaboration and converting technology advantages into product competitiveness and customer value.
The stated long-term aim is a life-health product and service system spanning multiple use cases and life stages, supporting high-quality and sustainable growth.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Bloomage BioTechnology
- H1 2026 revenue dropped 22%, net profit fell 31%, but gross margin stayed strong at 68%.688363
Q2 2026 - Revenue and profit fell, but cash flow improved as strategic transformation accelerates.688363Q1 2026
- Net profit jumped 67.59% despite a 21.82% revenue drop, driven by margin and cost improvements.688363Q4 2025
- Q3 net profit surged 55.63% year-over-year as operational quality and cash flow improved.688363Q3 2025
- Revenue and net profit declined sharply, but R&D and core margins remained strong.688363Q2 2025
- Q3 net profit plunged 77% year-over-year on lower sales and higher expenses.688363Q3 2024
- H1 2024 saw profit decline but strong growth in medical terminals and raw materials.688363Q2 2024
- Q1 profit fell 58% on weak skin science sales; strategic upgrades and R&D investment continue.688363Q1 2025
- Revenue and profit fell sharply amid strategic transformation and increased costs.688363Q4 2024
Next Bloomage BioTechnology earnings date
Q4 202622 Apr, 2027
Bloomage BioTechnology
Next Bloomage BioTechnology earnings date
Q4 202622 Apr, 2027
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)